Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Current Alzheimer's Disease (AD) treatments lack efficacy, with amyloid-targeting therapies failing in clinical trials.
• Amyloid pathology, while a hallmark of AD, presents significant challenges for therapeutic intervention due to low efficacy and adverse effects.
• Alternative therapeutic targets are crucial for addressing the complex pathology of AD and memory loss.

Purpose of the Study:

• To review the mechanisms underlying calcium (Ca2+) dysregulation in Alzheimer's Disease (AD).
• To explore the association between Ca2+ dysregulation and other AD pathologies, including inflammation, oxidative stress, and neurodegeneration.
• To discuss potential therapeutic strategies targeting Ca2+ dysregulation for AD treatment.

Main Methods:

• Literature review of studies investigating Ca2+ homeostasis in AD.
• Analysis of research on Ca2+ dysregulation in cytosolic space, Endoplasmic Reticulum (ER), and mitochondria in AD models.
• Examination of preclinical data on drugs and strategies aimed at correcting Ca2+ dysregulation in AD.

Main Results:

• Ca2+ dysregulation is increasingly recognized as a significant factor in AD pathogenesis.
• Imbalances in Ca2+ are linked to inflammation, reactive oxygen species (ROS), impaired autophagy, neurodegeneration, and synaptic dysfunction in AD.
• Preclinical studies show that correcting Ca2+ dysregulation can be a viable therapeutic approach for AD.

Conclusions:

• Ca2+ dysregulation is a critical contributor to Alzheimer's Disease (AD) pathology and cognitive decline.
• Targeting Ca2+ pathways presents a promising alternative to amyloid-centric approaches for AD drug development.
• Further research into Ca2+ modulating strategies could lead to novel disease-modifying treatments for AD.